Stock Events

Lonza 

S$79.97
118
+S$0+0% Tuesday 20:00

Statistics

Day High
-
Day Low
-
52W High
79.97
52W Low
79.97
Volume
-
Avg. Volume
0
Mkt Cap
5.96B
P/E Ratio
-
Dividend Yield
3.73%
Dividend
2.98

Upcoming

Dividends

3.73%Dividend Yield
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
15.55%
1Y Growth
14.27%

Earnings

25JulConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
0
2.71
5.42
8.13
Expected EPS
5.6460348
Actual EPS
7.808346

People Also Follow

This list is based on the watchlists of people on Stock Events who follow O6Z.SG. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap230.72B
Thermo Fisher Scientific offers similar biotechnology and pharmaceutical services, including contract manufacturing and development services, competing directly with Lonza's core business.
Danaher
DHR
Mkt Cap194.51B
Danaher Corporation, through its Life Sciences segment, competes in the bioprocessing space, offering products and services that overlap with Lonza's offerings in pharmaceutical development and manufacturing.
Charles River Laboratories International
CRL
Mkt Cap10.42B
Charles River Laboratories provides a range of preclinical and clinical laboratory services for the pharmaceutical, medical device, and biotechnology industries, competing with Lonza in contract development and manufacturing organization (CDMO) services.
IQVIA
IQV
Mkt Cap43.68B
IQVIA offers extensive clinical research services, including biopharmaceutical development, which competes with Lonza's services in drug development and manufacturing.
Catalent
CTLT
Mkt Cap10.78B
Catalent is a provider of delivery technologies, development, and manufacturing solutions for drugs, biologics, and consumer health products, directly competing with Lonza in drug development and delivery solutions.
West Pharmaceutical Services
WST
Mkt Cap21.79B
West Pharmaceutical Services specializes in designing and manufacturing containment and delivery systems for injectable drugs and healthcare products, competing with Lonza in the pharmaceutical and biotech supply chain.
Bio-Rad Laboratories
BIO
Mkt Cap9.08B
Bio-Rad Laboratories offers products and services in life science research and clinical diagnostics, competing with Lonza in the provision of specialized instruments and reagents for the pharmaceutical industry.

About

There is no Profile data available for O6Z.SI.
Show more...
CEO
Country
CH
ISIN
CH0013841017
WKN
000928619

Listings